These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 12802030)

  • 1. Aromatase inhibitors in breast cancer.
    Smith IE; Dowsett M
    N Engl J Med; 2003 Jun; 348(24):2431-42. PubMed ID: 12802030
    [No Abstract]   [Full Text] [Related]  

  • 2. New breast cancer drug.
    Brink S
    US News World Rep; 2001 Dec; 131(26):52. PubMed ID: 11793594
    [No Abstract]   [Full Text] [Related]  

  • 3. Focus on anastrozole and breast cancer.
    Mokbel K
    Curr Med Res Opin; 2003; 19(8):683-8. PubMed ID: 14687437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical differences among the aromatase inhibitors.
    Ligibel JA; Winer EP
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):473S-9S. PubMed ID: 12538503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase inhibitors for hormonal therapy of early-stage breast cancer.
    Traina TA; Dickler MN
    Curr Opin Investig Drugs; 2004 Jun; 5(6):605-10. PubMed ID: 15242248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibitors for breast cancer prevention.
    Cuzick J
    J Clin Oncol; 2005 Mar; 23(8):1636-43. PubMed ID: 15755971
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aromatase inhibitors].
    Krysiak R; Okopień B; Herman ZS
    Pol Arch Med Wewn; 2004 Mar; 111(3):375-84. PubMed ID: 15230221
    [No Abstract]   [Full Text] [Related]  

  • 8. Aromatase inhibitors as adjuvant therapy for breast cancer.
    Montemurro F; Aglietta M; Del Mastro L
    J Clin Oncol; 2009 May; 27(15):2566-7. PubMed ID: 19332706
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions of antioestrogens and aromatase inhibitors.
    Schmid P; Possinger K
    Forum (Genova); 2002; 12(1):45-59. PubMed ID: 12634910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aromatase inhibitors: therapeutic outlook].
    Namer M
    Bull Cancer; 2000 Dec; 87 Spec No():41-5. PubMed ID: 11250607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.
    Tamaki Y; Miyoshi Y; Kim SJ; Tanji Y; Taguchi T; Noguchi S
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):193-201. PubMed ID: 12722879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute benefits of aromatase inhibitors in adjuvant treatment of breast cancer: should we know more?
    Seruga B; Ocana A; Niraula S; Amir E
    J Clin Oncol; 2010 Jul; 28(20):e346-7; author reply e348. PubMed ID: 20458046
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
    Friedrichs K; Jänicke F
    Praxis (Bern 1994); 1998 Apr; 87(17):584-8. PubMed ID: 9623325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical overview of aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancer.
    Younus J; Vandenberg TA
    Bull Cancer; 2005 Apr; 92(4):E39-44. PubMed ID: 15888383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New developments in the hormonal treatment of breast cancer in postmenopausal women].
    Trunet P; Marty M
    Bull Cancer; 1999 Oct; 86(10):815-20. PubMed ID: 10572232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aromatase inhibitors in risk reduction of breast cancer: potential use in premenopausal women].
    Kubatka P; Péc M
    Klin Onkol; 2009; 22(6):268-72. PubMed ID: 20099744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors and breast cancer.
    Miller WR
    Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selective oral aromatase suppression and thymidilate synthase inhibition].
    Chirurg; 1997 Feb; 68(2 Suppl):1-16. PubMed ID: 9131060
    [No Abstract]   [Full Text] [Related]  

  • 19. Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence?
    Dixon JM
    Breast; 2008 Aug; 17(4):353-60. PubMed ID: 18490163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting.
    Winer EP; Hudis C; Burstein HJ; Bryant J; Chlebowski RT; Ingle JN; Edge SB; Mamounas EP; Gelber R; Gralow J; Goldstein LJ; Pritchard KI; Braun S; Cobleigh MA; Langer AS; Perotti J; Powles TJ; Whelan TJ; Browman GP
    J Clin Oncol; 2003 Jul; 21(13):2597-9. PubMed ID: 12732612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.